Tg Therapeutics Inc (TGTX)

06:04 AM

TG Therapeutics, Inc. $TGTX Shares Bought by Public Sector Pension Investment Board - MarketBeat

06:04 AM

03:42 AM

TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

03:42 AM

Feb 13, 2026

What is TG Therapeutics Inc.’s valuation compared to sectorJuly 2025 Opening Moves & Verified Momentum Stock Ideas - mfd.ru

Feb 13, 2026

Feb 11, 2026

Goldman Sachs Raises TG Therapeutics, Inc. (TGTX) Target to $39 on 2026 Guidance - Finviz

Feb 11, 2026

Feb 11, 2026

TGTX News Today | Why did TG Therapeutics stock go down today? $TGTX - MarketBeat

Feb 11, 2026

Feb 10, 2026

Should you avoid TG Therapeutics Inc. stock right now2025 Sector Review & Free Risk Controlled Daily Trade Plans - mfd.ru

Feb 10, 2026

Feb 10, 2026

Why TG Therapeutics Inc. (NKB2) stock gets analyst attentionTrade Entry Report & Community Supported Trade Ideas - mfd.ru

Feb 10, 2026

Feb 10, 2026

10 Best Long Term Healthcare Stocks to Buy - Insider Monkey

Feb 10, 2026

Feb 10, 2026

TG Therapeutics (TGTX) sees price target drop from JPMorgan - MSN

Feb 10, 2026

Feb 09, 2026

Should New BRIUMVI Data and MS Campaign Shift TG Therapeutics' (TGTX) Narrative on Commercial Execution? - Yahoo Finance

Feb 09, 2026

Feb 09, 2026

TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' - Stocktwits

Feb 09, 2026

Feb 09, 2026

MSFT Vs AMZN Vs GOOGL: Which Cloud Stock Is A Better Bet? - Stocktwits

Feb 09, 2026

Feb 08, 2026

TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - GlobeNewswire

Feb 08, 2026

Feb 08, 2026

Christina Applegate fronts new MS honesty campaign with TG Therapeutics - Stock Titan

Feb 08, 2026

Feb 08, 2026

TG Therapeutics Partners with Christina Applegate to Raise MS Awareness - intellectia.ai

Feb 08, 2026

Feb 07, 2026

TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan - Finviz

Feb 07, 2026

Feb 06, 2026

TG Therapeutics presents BRIUMVI data at ACTRIMS forum By Investing.com - Investing.com Nigeria

Feb 06, 2026

Feb 06, 2026

TG Therapeutics stock pops as Briumvi boom reignites bull case: Goldman Sachs sees room for 32% rally - MSN

Feb 06, 2026

Feb 06, 2026

TG Therapeutics Presents BRIUMVI Data at ACTRIMS Annual Meeting - Intellectia AI

Feb 06, 2026

Feb 06, 2026

TG Therapeutics presents BRIUMVI data at ACTRIMS forum - Investing.com

Feb 06, 2026

Feb 06, 2026

TG Therapeutics rises on new data for autoimmune therapy - TradingView

Feb 06, 2026

Feb 06, 2026

TG Therapeutics Presents New Data on BRIUMVI® at ACTRIMS 2026 Annual Forum - Quiver Quantitative

Feb 06, 2026

Feb 06, 2026

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum - The Manila Times

Feb 06, 2026

Feb 06, 2026

TG Therapeutics Announces Presentation of Data for BRIUMVI® - GlobeNewswire

Feb 06, 2026

Feb 05, 2026

Aug Intraday: Is TG Therapeutics Inc a turnaround story2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Feb 05, 2026

Feb 05, 2026

Why (TGTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Feb 05, 2026

Feb 05, 2026

RSI Check: Should you avoid TG Therapeutics Inc stock right nowQuarterly Profit Summary & Free Technical Confirmation Trade Alerts - baoquankhu1.vn

Feb 05, 2026

Feb 04, 2026

TG Therapeutics (NASDAQ:TGTX) Takes On Some Risk With Its Use Of Debt - 富途牛牛

Feb 04, 2026

Feb 04, 2026

TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth - Investing.com Canada

Feb 04, 2026

Feb 03, 2026

Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares - AOL.com

Feb 03, 2026

Feb 02, 2026

JP Morgan Adjusts Price Target for TGTX, Maintains Overweight Ra - GuruFocus

Feb 02, 2026

Feb 02, 2026

JPMorgan Chase & Co. Issues Pessimistic Forecast for TG Therapeutics (NASDAQ:TGTX) Stock Price - MarketBeat

Feb 02, 2026

Feb 02, 2026

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring the 52.42% Potential Upside and Strategic Positioning in Biotechnology - DirectorsTalk Interviews

Feb 02, 2026

Jan 31, 2026

Quarterly Trades: Will TG Therapeutics Inc benefit from AI trendsWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

Universal Beteiligungs und Servicegesellschaft mbH Has $2.29 Million Stake in TG Therapeutics, Inc. $TGTX - MarketBeat

Jan 30, 2026

Jan 27, 2026

TG Therapeutics Readies New BRIUMVI Data As Market Weighs Valuation - Sahm

Jan 27, 2026

Jan 27, 2026

Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Weakness And BRIUMVI Growth Assumptions - Yahoo Finance

Jan 27, 2026

Jan 27, 2026

TG Therapeutics to present BRIUMVI data at ACTRIMS forum By Investing.com - Investing.com Canada

Jan 27, 2026

Jan 27, 2026

TG Therapeutics to present BRIUMVI data at ACTRIMS forum - Investing.com

Jan 27, 2026

Jan 27, 2026

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum - The Manila Times

Jan 27, 2026

Jan 27, 2026

TG Therapeutics Highlights Upcoming BRIUMVI® Presentations at ACTRIMS 2026 Annual Forum - Quiver Quantitative

Jan 27, 2026

Jan 26, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 43.77% Potential Upside - DirectorsTalk Interviews

Jan 26, 2026

Jan 25, 2026

Understanding Momentum Shifts in (TGTX) - Stock Traders Daily

Jan 25, 2026

Jan 24, 2026

TG Therapeutics Achieves 8.54% Return; Birkenstock Reports -31.21% Loss - Markets Mojo

Jan 24, 2026

Jan 23, 2026

Analysts Conflicted on These Healthcare Names: Hinge Health, Inc. Class A (HNGE), Axsome Therapeutics (AXSM) and TG Therapeutics (TGTX) - The Globe and Mail

Jan 23, 2026

Jan 23, 2026

Is TG Therapeutics (TGTX) Pricing Reflecting Its Strong DCF And P/E Valuation Signals? - Sahm

Jan 23, 2026

Jan 22, 2026

Why TG Therapeutics (TGTX) Is Up 6.9% After Issuing 2026 BRIUMVI-Centric Revenue Guidance And What's Next - Sahm

Jan 22, 2026